Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Gross Margin (2017 - 2025)

Inspire Medical Systems' Gross Margin history spans 9 years, with the latest figure at 86.59% for Q4 2025.

  • For Q4 2025, Gross Margin rose 161.0% year-over-year to 86.59%; the TTM value through Dec 2025 reached 85.39%, up 71.0%, while the annual FY2025 figure was 85.39%, 71.0% up from the prior year.
  • Gross Margin for Q4 2025 was 86.59% at Inspire Medical Systems, up from 85.85% in the prior quarter.
  • Across five years, Gross Margin topped out at 86.59% in Q4 2025 and bottomed at 81.88% in Q3 2022.
  • The 5-year median for Gross Margin is 84.84% (2024), against an average of 84.83%.
  • The largest annual shift saw Gross Margin crashed -414bps in 2022 before it soared 222bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 85.77% in 2021, then decreased by -2bps to 83.94% in 2022, then rose by 2bps to 85.43% in 2023, then decreased by -1bps to 84.99% in 2024, then grew by 2bps to 86.59% in 2025.
  • Per Business Quant, the three most recent readings for INSP's Gross Margin are 86.59% (Q4 2025), 85.85% (Q3 2025), and 84.03% (Q2 2025).